Quality of life of people with rheumatoid arthritis as measured by the World Health Organization Quality of Life Instrument, Short Form (WHOQOL-BREF): Score distributions and psychometric properties
Article first published online: 3 JUN 2004
Copyright © 2004 by the American College of Rheumatology
Arthritis Care & Research
Volume 51, Issue 3, pages 350–357, 15 June 2004
How to Cite
Taylor, W. J., Myers, J., Simpson, R. T., McPherson, K. M. and Weatherall, M. (2004), Quality of life of people with rheumatoid arthritis as measured by the World Health Organization Quality of Life Instrument, Short Form (WHOQOL-BREF): Score distributions and psychometric properties. Arthritis & Rheumatism, 51: 350–357. doi: 10.1002/art.20398
- Issue published online: 3 JUN 2004
- Article first published online: 3 JUN 2004
- Manuscript Accepted: 27 AUG 2003
- Manuscript Received: 26 DEC 2002
- Health Research Council of New Zealand. Grant Number: 99/568/CL/PJ/UOFO
- Otago research grant. Grant Number: 98/778
- 20The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials: the Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993; 36: 729–40., , , , , , et al.
- 21Australian WHOQoL instruments: user's manual and interpretation guide. Melbourne, Australia: Australian WHOQoL Field Study Centre; 2000., , , , .
- 22Construction and utility scaling of the Assessment of Quality of Life (AQoL) instrument. Melbourne, Australia: Centre for Health Program Evaluation; 2000., , , , .
- 23Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994., .
- 24Factor analysis. In: Staquet MJ, Hays RD, Fayers PM, editors. Quality of life assessment in clinical trials: methods and practice. New York: Oxford University Press; 1998., .
- 34Leflunomide Rheumatoid Arthritis Investigators Group. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Arthritis Rheum 2000; 43: 506–14., , , , , , et al,